Both prognostic genes appear to be expressed in the stroma, with upregulation of TAGLN in gastric stromal carcinoma-associated fibroblasts (40), and increased expression of THBS2 implicated in tumor progression and poor prognosis in pancreatic cancer, excreted by stromal fibroblasts (41). This evidence concerns the gene TAGLN and familial pancreatic carcinoma.